Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
α1-FANGs: Protein Ligands Selective for the α-Bungarotoxin Site of the α1-Nicotinic Acetylcholine Receptor.
Nichols AL
,
Noridomi K
,
Hughes CR
,
Jalali-Yazdi F
,
Eaton JB
,
Lai LH
,
Advani G
,
Lukas RJ
,
Lester HA
,
Chen L
,
Roberts RW
.
???displayArticle.abstract???
Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels that play a central role in neuronal and neuromuscular signal transduction. Here, we have developed FANG ligands, fibronectin antibody-mimetic nicotinic acetylcholine receptor-generated ligands, using mRNA display. We generated a 1 trillion-member primary e10FnIII library to target a stabilized α1 nicotinic subunit (α211). This library yielded 270000 independent potential protein binding ligands. The lead sequence, α1-FANG1, represented 25% of all library sequences, showed the highest-affinity binding, and competed with α-bungarotoxin (α-Btx). To improve this clone, a new library based on α1-FANG1 was subjected to heat, protease, binding, off-rate selective pressures, and point mutations. This resulted in α1-FANG2 and α1-FANG3. These proteins bind α211 with KD values of 3.5 nM and 670 pM, respectively, compete with α-Btx, and show improved subunit specificity. α1-FANG3 is thermostable ( Tm = 62 °C) with a 6 kcal/mol improvement in folding free energy compared with that of the parent α1-FANG1. α1-FANG3 competes directly with the α-Btx binding site of intact neuromuscular heteropentamers [(α1)2β1γδ] in mammalian culture-derived cellular membranes and in Xenopus laevis oocytes expressing these nAChRs. This work demonstrates that mRNA display against a monomeric ecto-domain of a pentamer has the capability to select ligands that bind that subunit in both a monomeric and a pentameric context. Overall, our work provides a route to creating a new family of stable, well-behaved proteins that specifically target this important receptor family.
Arias,
Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
2000, Pubmed
Arias,
Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
2000,
Pubmed
Baker,
Pharmacological properties of alpha 9 alpha 10 nicotinic acetylcholine receptors revealed by heterologous expression of subunit chimeras.
2004,
Pubmed
,
Xenbase
Bracci,
Binding of HIV-1 gp120 to the nicotinic receptor.
1992,
Pubmed
Brejc,
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
2001,
Pubmed
Changeux,
Use of a snake venom toxin to characterize the cholinergic receptor protein.
1970,
Pubmed
Corringer,
Nicotinic receptors at the amino acid level.
2000,
Pubmed
Das,
A simple method of mouse lung intubation.
2013,
Pubmed
Davies,
Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors.
1999,
Pubmed
Dellisanti,
Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution.
2007,
Pubmed
Greenfield,
Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions.
2006,
Pubmed
Gross,
Recombinant probes for visualizing endogenous synaptic proteins in living neurons.
2013,
Pubmed
Hilz,
Stimulation of proteinase K action by denaturing agents: application to the isolation of nucleic acids and the degradation of 'masked' proteins.
1975,
Pubmed
Hunt,
The electron microscopic autoradiographic localization of alpha-bungarotoxin binding sites within the central nervous system of the rat.
1978,
Pubmed
Hurst,
Nicotinic acetylcholine receptors: from basic science to therapeutics.
2013,
Pubmed
Jalali-Yazdi,
High-Throughput Measurement of Binding Kinetics by mRNA Display and Next-Generation Sequencing.
2016,
Pubmed
Kasheverov,
Naturally occurring and synthetic peptides acting on nicotinic acetylcholine receptors.
2009,
Pubmed
Lentz,
Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor.
1987,
Pubmed
Lester,
Cys-loop receptors: new twists and turns.
2004,
Pubmed
Lester,
Vulnerability of desensitized or curare-treated acetylcholine receptors to irreversible blockade by cobra toxin.
1972,
Pubmed
Liao,
mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein.
2009,
Pubmed
Miwa,
Optimizing cholinergic tone through lynx modulators of nicotinic receptors: implications for plasticity and nicotine addiction.
2012,
Pubmed
Moise,
NMR structural analysis of alpha-bungarotoxin and its complex with the principal alpha-neurotoxin-binding sequence on the alpha 7 subunit of a neuronal nicotinic acetylcholine receptor.
2002,
Pubmed
Motamed,
Potentiation of mivacurium blockade by low dose of pancuronium: a pharmacokinetic study.
2003,
Pubmed
Nirthanan,
Three-finger alpha-neurotoxins and the nicotinic acetylcholine receptor, forty years on.
2004,
Pubmed
Olson,
Rapid mRNA-display selection of an IL-6 inhibitor using continuous-flow magnetic separation.
2011,
Pubmed
Olson,
Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain.
2007,
Pubmed
Olson,
mRNA display selection of a high-affinity, modification-specific phospho-IkappaBalpha-binding fibronectin.
2008,
Pubmed
Qasim,
Specificity of proteinase K at P2 to P3' sub-sites and its comparison to other serine proteases.
2014,
Pubmed
Roberts,
RNA-peptide fusions for the in vitro selection of peptides and proteins.
1997,
Pubmed
Sine,
Recent advances in Cys-loop receptor structure and function.
2006,
Pubmed
Smart,
Synaptic neurotransmitter-gated receptors.
2012,
Pubmed
Smith,
A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients.
1997,
Pubmed
Takahashi,
mRNA display: ligand discovery, interaction analysis and beyond.
2003,
Pubmed
Wang,
Assembly of the nicotinic acetylcholine receptor. The first transmembrane domains of truncated alpha and delta subunits are required for heterodimer formation in vivo.
1996,
Pubmed
Yao,
Yeast expression and NMR analysis of the extracellular domain of muscle nicotinic acetylcholine receptor alpha subunit.
2002,
Pubmed
